查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575444

栓塞顆粒市場：按產品類型、應用、最終用戶、材料、尺寸分類 - 2025-2030 年全球預測

Embolization Particle Market by Product Type (Drug-Eluting Beads, Microspheres, PVA Particles), Application (Neurology, Oncology, Peripheral Vascular Disease), End-User, Material, Size - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年栓塞顆粒市場估值為16億美元，預計2024年將達17.9億美元，複合年成長率為11.21%，預計到2030年將達到33.7億美元。

栓塞顆粒是指醫療手術中使用的微小球體或其他形狀的材料，以閉塞血管，從而控制或預防出血、切斷腫瘤的血液供應，或治療動靜脈畸形並對其進行處理。醫學領域非常需要其微創有效治療子宮肌瘤、肝癌、消化道出血等複雜病症。最終用途範圍主要包括依賴先進介入放射技術的醫院和專業臨床機構。微創手術需求的增加、放射治療的進步以及更容易患血管疾病和癌症的人口老化推動了栓塞顆粒市場的成長。隨著技術進步使客製化治療方法更加有效，腫瘤學和個人化醫療的應用可能會擴大。醫療基礎設施不斷改善的新興市場也為市場擴張提供了豐厚的機會。公司可以透過投資研究開發具有增強生物相容性和靶向能力的新型栓塞材料來抓住這些機會。然而，高成本、監管挑戰以及與手術相關的風險等限制因素正在阻礙市場成長。此外，在介入放射學仍處於起步階段的地區，執行此類手術的培訓和技能要求也可能是一個限制。創新的關鍵領域包括開發生物分解性和藥物釋放型顆粒，以提高安全性和治療效果。另一個成長途徑是使用人工智慧來提高手術過程中的影像處理和瞄準精度。這個市場既是技術主導的，也是競爭激烈的，需要不斷創新並遵守嚴格的監管標準。公司將專注於與醫療機構合作進行臨床試驗和回饋，並在開發週期的早期與監管機構合作，以簡化核准流程並縮短新產品的上市時間。

主要市場統計
基準年[2023] 16億美元
預測年份 [2024] 17.9億美元
預測年份 [2030] 33.7億美元
複合年成長率（%） 11.21%

市場動態：快速發展的栓塞顆粒市場的關鍵市場洞察

供需的動態交互作用正在改變栓塞顆粒市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 技術與成像模式的整合提高了栓塞的準確性和有效性
    • 改進醫療保健專業人員的培訓計劃，提高栓塞熟練程度
    • 以患者為中心的方法和客製化的治療計劃是栓塞實踐的核心
  • 市場限制因素
    • 栓塞程序和顆粒的高成本
  • 市場機會
    • 對微創治療的需求不斷成長推動栓塞顆粒市場成長
    • 技術進步和創新帶來栓塞顆粒的卓越性能和新應用
    • 政府和私營部門投資促進栓塞顆粒技術的研發
  • 市場挑戰
    • 與栓塞相關的併發症和風險

波特的五力：駕馭栓塞顆粒市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解栓塞顆粒市場的外部影響

外部宏觀環境因素在塑造栓塞顆粒市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解栓塞顆粒市場的競爭格局

對栓塞顆粒市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位基質栓塞顆粒市場供應商的表現評估

FPNV定位矩陣是評估栓塞顆粒市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了栓塞顆粒市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對栓塞顆粒市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 與診斷成像設備的技術整合提高了栓塞的準確性和有效性
      • 加強醫護人員訓練計畫將提升他們使用栓塞技術的能力。
      • 以患者為中心的方法和客製化的治療計劃是栓塞實踐的關鍵
    • 抑制因素
      • 栓塞和顆粒的高成本
    • 機會
      • 微創手術需求的增加推動栓塞顆粒市場的成長
      • 技術進步和創新帶來栓塞顆粒的卓越性能和新應用
      • 政府和私營部門的投資推動了栓塞顆粒技術的研究和開發
    • 任務
      • 與栓塞相關的併發症和風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章栓塞顆粒市場：依產品類型

  • 藥物釋放型珠
  • 微球
  • 聚乙烯醇顆粒
  • 放射栓塞顆粒
  • 三丙烯酸明膠顆粒

第7章栓塞顆粒市場：依應用分類

  • 神經病學
  • 腫瘤學
  • 周圍血管疾病
  • 泌尿系統

第 8 章 栓塞顆粒市場：依最終使用者分類

  • 門診手術中心
  • 醫院
  • 研究/學術機構
  • 專科診所

第9章栓塞顆粒市場：依材料分類

  • 丙烯酸聚合物
  • 明膠
  • 聚乙烯醇（PVA）

第 10 章 栓塞顆粒市場：依規模

  • 100-300微米
  • 300-500微米
  • 500-700微米
  • 700-900微米
  • 900微米以上
  • 小於100微米

第11章：美洲的栓塞顆粒市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章：亞太地區栓塞顆粒市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的栓塞顆粒市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-2B5802CFE14F

The Embolization Particle Market was valued at USD 1.60 billion in 2023, expected to reach USD 1.79 billion in 2024, and is projected to grow at a CAGR of 11.21%, to USD 3.37 billion by 2030.

Embolization particles refer to tiny spheres or other shaped materials used in medical procedures to block blood vessels, thereby controlling or preventing bleeding, cutting off blood supply to tumors, or addressing arteriovenous malformations. Their necessity in the medical field is significant due to their minimally invasive nature and efficacy in treating complex conditions like uterine fibroids, liver cancer, and gastrointestinal bleeding. The end-use scope primarily includes hospitals and specialized clinical settings, which rely on advanced interventional radiology techniques. Market growth for embolization particles is driven by increasing demand for minimally invasive surgery, advances in radiological procedures, and an aging population prone to vascular diseases and cancer. Potential opportunities lie in expanding applications in oncology and personalized medicine as technological advancements make tailored treatment approaches more effective. Emerging markets with improving healthcare infrastructure also offer lucrative opportunities for market expansion. Companies can capture these opportunities by investing in research to develop novel embolic materials with enhanced biocompatibility and targeting capabilities. However, limitations such as high costs, regulatory challenges, and risks associated with procedures present obstacles to market growth. Training and skill requirements for conducting such procedures can also be a restraint in regions where interventional radiology is still developing. Key areas of innovation include developing biodegradable and drug-eluting particles, which can enhance safety and therapeutic outcomes. Leveraging artificial intelligence for improved imaging and targeting precision during procedures represents another avenue for growth. The nature of this market is both technology-driven and highly competitive, demanding continuous innovation and adherence to strict regulatory standards. Businesses should focus on partnerships with healthcare institutions for clinical trials and feedback, as well as engaging with regulatory bodies early in the development cycle to streamline approval processes and reduce time-to-market for new products.

KEY MARKET STATISTICS
Base Year [2023] USD 1.60 billion
Estimated Year [2024] USD 1.79 billion
Forecast Year [2030] USD 3.37 billion
CAGR (%) 11.21%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Embolization Particle Market

The Embolization Particle Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Technological integration with imaging modalities improves precision and efficacy of embolization procedures
    • Enhanced training programs for healthcare professionals increase proficiency in using embolization technologies
    • Patient-centric approaches and customized treatment plans gain prominence in embolization practices
  • Market Restraints
    • High cost of embolization procedures and particles
  • Market Opportunities
    • Increasing demand for minimally invasive procedures to drive growth in embolization particle market
    • Technological advancements and innovation leading to superior performance and new applications of embolization particles
    • Government and private sector investments boosting research and development in embolization particle technologies
  • Market Challenges
    • Complications and risks associated with embolization

Porter's Five Forces: A Strategic Tool for Navigating the Embolization Particle Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Embolization Particle Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Embolization Particle Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Embolization Particle Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Embolization Particle Market

A detailed market share analysis in the Embolization Particle Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Embolization Particle Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Embolization Particle Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Embolization Particle Market

A strategic analysis of the Embolization Particle Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Embolization Particle Market, highlighting leading vendors and their innovative profiles. These include ABK Biomedical, Bellostent, Biocompatibles International plc, Boston Scientific Corporation, BTG plc, Cook Medical, EndoShape, Guerbet Group, Hanger Inc., Imbiotechnologies, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Merit Medical Systems, Penumbra Inc., Sequent Medical, Sirtex Medical, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Embolization Particle Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Drug-Eluting Beads, Microspheres, PVA Particles, Radioembolization Particles, and Tris-Acryl Gelatin Particles.
  • Based on Application, market is studied across Neurology, Oncology, Peripheral Vascular Disease, and Urology.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Research and Academic Institutes, and Specialty Clinics.
  • Based on Material, market is studied across Acrylic Polymers, Gelatin, and Polyvinyl Alcohol (PVA).
  • Based on Size, market is studied across 100-300 Microns, 300-500 Microns, 500-700 Microns, 700-900 Microns, 900 Microns and Above, and Less Than 100 Microns.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Technological integration with imaging modalities improves precision and efficacy of embolization procedures
      • 5.1.1.2. Enhanced training programs for healthcare professionals increase proficiency in using embolization technologies
      • 5.1.1.3. Patient-centric approaches and customized treatment plans gain prominence in embolization practices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of embolization procedures and particles
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for minimally invasive procedures to drive growth in embolization particle market
      • 5.1.3.2. Technological advancements and innovation leading to superior performance and new applications of embolization particles
      • 5.1.3.3. Government and private sector investments boosting research and development in embolization particle technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Complications and risks associated with embolization
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Embolization Particle Market, by Product Type

  • 6.1. Introduction
  • 6.2. Drug-Eluting Beads
  • 6.3. Microspheres
  • 6.4. PVA Particles
  • 6.5. Radioembolization Particles
  • 6.6. Tris-Acryl Gelatin Particles

7. Embolization Particle Market, by Application

  • 7.1. Introduction
  • 7.2. Neurology
  • 7.3. Oncology
  • 7.4. Peripheral Vascular Disease
  • 7.5. Urology

8. Embolization Particle Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Research and Academic Institutes
  • 8.5. Specialty Clinics

9. Embolization Particle Market, by Material

  • 9.1. Introduction
  • 9.2. Acrylic Polymers
  • 9.3. Gelatin
  • 9.4. Polyvinyl Alcohol (PVA)

10. Embolization Particle Market, by Size

  • 10.1. Introduction
  • 10.2. 100-300 Microns
  • 10.3. 300-500 Microns
  • 10.4. 500-700 Microns
  • 10.5. 700-900 Microns
  • 10.6. 900 Microns and Above
  • 10.7. Less Than 100 Microns

11. Americas Embolization Particle Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Embolization Particle Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Embolization Particle Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABK Biomedical
  • 2. Bellostent
  • 3. Biocompatibles International plc
  • 4. Boston Scientific Corporation
  • 5. BTG plc
  • 6. Cook Medical
  • 7. EndoShape
  • 8. Guerbet Group
  • 9. Hanger Inc.
  • 10. Imbiotechnologies
  • 11. Johnson & Johnson
  • 12. Kaneka Corporation
  • 13. Medtronic plc
  • 14. Merit Medical Systems
  • 15. Penumbra Inc.
  • 16. Sequent Medical
  • 17. Sirtex Medical
  • 18. Stryker Corporation
  • 19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. EMBOLIZATION PARTICLE MARKET RESEARCH PROCESS
  • FIGURE 2. EMBOLIZATION PARTICLE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EMBOLIZATION PARTICLE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EMBOLIZATION PARTICLE MARKET DYNAMICS
  • TABLE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PVA PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY RADIOEMBOLIZATION PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TRIS-ACRYL GELATIN PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 100-300 MICRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 300-500 MICRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 500-700 MICRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 700-900 MICRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 900 MICRONS AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LESS THAN 100 MICRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 243. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 244. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2023